2020


July: Finding the cure for Parkinson’s disease with camel nanobodies

With a donation from the Lundbeck Foundation, Daniel Otzen and his’ team of researchers hope to develop the first cure for Parkinson’s disease. One of the methods employs nanobodies derived from alpaca llamas.

July: Starting from square one to understand Parkinson’s disease

With a grant from the Lundbeck Foundation, scientist Per Borghammer has set out to test a hypothesis on why Parkinson’s disease occur.

July: Probe smaller than a human hair to map the brain

Researchers are looking at creating a tool to penetrate animal brains and reveal neural activity. The team behind the research is using the newest optical fiber technology.

July: We are doubling down on antibody research

The partnership allows Lundbeck a new way to assess if antibodies enter the human brain, thereby ensuring faster progression in Lundbeck’s drug development with a potential increased likelihood of clinical success.

May: Lundbeck is part of the largest ever UN-backed CEO-led climate advocacy effort

Lundbeck is together with over 150 global corporations, The Science Based Targets initiative, the UN Global Compact, and the We Mean Business Coalition urging governments around the world to align their COVID-19 economic aid and recovery efforts with ambitious climate action.

April: Partnering with Patient Groups and Working to Restore Brain Health

In a worldwide survey, Lundbeck is ranked 15 out of 48 or the world’s top pharma companies for corporate reputation among patient groups.

Cookie Policy
You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.